Head and Neck Cancer Clinical Trials in Beijing
2 recruitingBeijing, China
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
Study of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced NSCLC and Other Solid Tumors
Colorectal, CancerHead and Neck CancerNon-small Cell Lung Cancer+1 more
Betta Pharmaceuticals Co., Ltd.400 enrolled87 locationsNCT04930432
Recruiting
Phase 2
Response Adaptive Radiotherapy Following Immunotherapy-based Induction for Non-HPV Related HNSCC
Head and Neck Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences133 enrolled1 locationNCT06345287